ATE164883T1 - Verfahren zur vorbereitung von doppel strangiger rna und seine anwendungen - Google Patents

Verfahren zur vorbereitung von doppel strangiger rna und seine anwendungen

Info

Publication number
ATE164883T1
ATE164883T1 AT93902352T AT93902352T ATE164883T1 AT E164883 T1 ATE164883 T1 AT E164883T1 AT 93902352 T AT93902352 T AT 93902352T AT 93902352 T AT93902352 T AT 93902352T AT E164883 T1 ATE164883 T1 AT E164883T1
Authority
AT
Austria
Prior art keywords
pct
double stranded
stranded rna
applications
date jun
Prior art date
Application number
AT93902352T
Other languages
English (en)
Inventor
Thierry Livache
Brigitte Fouque
Robert Teoule
Original Assignee
Cis Bio Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cis Bio Int filed Critical Cis Bio Int
Application granted granted Critical
Publication of ATE164883T1 publication Critical patent/ATE164883T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/26—Preparation of nitrogen-containing carbohydrates
    • C12P19/28—N-glycosides
    • C12P19/30—Nucleotides
    • C12P19/34—Polynucleotides, e.g. nucleic acids, oligoribonucleotides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844—Nucleic acid amplification reactions
    • C12Q1/6865—Promoter-based amplification, e.g. nucleic acid sequence amplification [NASBA], self-sustained sequence replication [3SR] or transcription-based amplification system [TAS]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT93902352T 1991-12-18 1992-12-18 Verfahren zur vorbereitung von doppel strangiger rna und seine anwendungen ATE164883T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9115710A FR2685346B1 (fr) 1991-12-18 1991-12-18 Procede de preparation d'arn double-brin, et ses applications.

Publications (1)

Publication Number Publication Date
ATE164883T1 true ATE164883T1 (de) 1998-04-15

Family

ID=9420171

Family Applications (1)

Application Number Title Priority Date Filing Date
AT93902352T ATE164883T1 (de) 1991-12-18 1992-12-18 Verfahren zur vorbereitung von doppel strangiger rna und seine anwendungen

Country Status (7)

Country Link
US (1) US5795715A (de)
EP (1) EP0618966B1 (de)
JP (1) JP3515108B2 (de)
AT (1) ATE164883T1 (de)
DE (1) DE69225074T2 (de)
FR (1) FR2685346B1 (de)
WO (1) WO1993012229A1 (de)

Families Citing this family (100)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6605712B1 (en) * 1990-12-20 2003-08-12 Arch Development Corporation Gene transcription and ionizing radiation: methods and compositions
FR2706465B1 (fr) * 1993-06-11 1995-08-25 Heliosynthese Sa Procédé de production et d'extraction de superoxyde-dismutases thermostables à partir d'une culture de micro-organismes photosynthétiques.
US6509149B2 (en) 1995-06-06 2003-01-21 Hybridon, Inc. HPV-specific oligonucleotides
US20030055240A1 (en) * 1995-06-06 2003-03-20 Roberts Peter C. HPV specific oligonucleotides
US6458940B2 (en) * 1995-06-06 2002-10-01 Hybridon, Inc. HPV-specific oligonucleotides
US6274369B1 (en) * 1996-02-02 2001-08-14 Invitrogen Corporation Method capable of increasing competency of bacterial cell transformation
US6506559B1 (en) 1997-12-23 2003-01-14 Carnegie Institute Of Washington Genetic inhibition by double-stranded RNA
KR20010042069A (ko) * 1998-03-20 2001-05-25 베니텍 오스트레일리아 리미티드 유전자 발현 조절방법
AUPP249298A0 (en) * 1998-03-20 1998-04-23 Ag-Gene Australia Limited Synthetic genes and genetic constructs comprising same I
EP2314700A1 (de) * 1999-01-28 2011-04-27 Medical College of Georgia Research Institute, Inc Zusammensetzung und Verfahren zur in vivo und in vitro Abschwächung der Genexpression mittels dobbelsträngiger RNA
US20040138168A1 (en) * 1999-04-21 2004-07-15 Wyeth Methods and compositions for inhibiting the function of polynucleotide sequences
BR0009884A (pt) * 1999-04-21 2002-01-08 American Home Prod Processos e composições para a inibição da função das sequências de polinucleotìdeos
US7056661B2 (en) * 1999-05-19 2006-06-06 Cornell Research Foundation, Inc. Method for sequencing nucleic acid molecules
US6423885B1 (en) * 1999-08-13 2002-07-23 Commonwealth Scientific And Industrial Research Organization (Csiro) Methods for obtaining modified phenotypes in plant cells
WO2001029058A1 (en) * 1999-10-15 2001-04-26 University Of Massachusetts Rna interference pathway genes as tools for targeted genetic interference
US6326193B1 (en) 1999-11-05 2001-12-04 Cambria Biosciences, Llc Insect control agent
PT1309726E (pt) 2000-03-30 2010-03-08 Whitehead Biomedical Inst Mediadores de interferência por rna específicos de sequência de rna
US7700359B2 (en) * 2000-06-02 2010-04-20 Novartis Vaccines And Diagnostics, Inc. Gene products differentially expressed in cancerous cells
US6465217B1 (en) * 2000-07-05 2002-10-15 Paradigm Genetics, Inc. Methods and compositions for the modulation of chorismate synthase and chorismate mutase expression or activity in plants
US20080242627A1 (en) * 2000-08-02 2008-10-02 University Of Southern California Novel rna interference methods using dna-rna duplex constructs
US20020173478A1 (en) * 2000-11-14 2002-11-21 The Trustees Of The University Of Pennsylvania Post-transcriptional gene silencing by RNAi in mammalian cells
KR100909681B1 (ko) 2000-12-01 2009-07-29 막스-플랑크-게젤샤프트 츄어 푀르더룽 데어 비쎈샤프텐 에.파우. Ｒｎａ 간섭을 매개하는 작은 ｒｎａ 분자
US20020132257A1 (en) * 2001-01-31 2002-09-19 Tony Giordano Use of post-transcriptional gene silencing for identifying nucleic acid sequences that modulate the function of a cell
US20030082685A1 (en) * 2001-04-06 2003-05-01 WEICHSELBAUM Ralph R. Chemotherapeutic induction of egr-1 promoter activity
US20040242523A1 (en) * 2003-03-06 2004-12-02 Ana-Farber Cancer Institue And The Univiersity Of Chicago Chemo-inducible cancer gene therapy
US8034791B2 (en) 2001-04-06 2011-10-11 The University Of Chicago Activation of Egr-1 promoter by DNA damaging chemotherapeutics
WO2004059289A2 (en) * 2001-05-22 2004-07-15 Epicentre Technologies Target-dependent transcription using deletion mutants of n4 rna polymerase
AUPR621501A0 (en) 2001-07-06 2001-08-02 Commonwealth Scientific And Industrial Research Organisation Delivery of ds rna
TWI335938B (en) * 2001-08-15 2011-01-11 Rna replication and amplification
ATE510016T1 (de) 2001-11-09 2011-06-15 Basf Plant Science Gmbh Mit stress assoziierte transkriptionsfaktor- spezifische polypeptide und verfahren zur verwendung in pflanzen
EP2189524A3 (de) 2001-11-09 2010-07-07 BASF Plant Science GmbH Proteinkinase-stressbedingte Polypeptide und Verwendungsverfahren für Pflanzen
EP1472375B1 (de) 2002-01-08 2009-04-01 Novartis Vaccines and Diagnostics, Inc. In kanzerösen mammazellen differentiell exprimierte genprodukte und ihre verwendungsverfahren
EP1572902B1 (de) * 2002-02-01 2014-06-11 Life Technologies Corporation HOCHWIRKSAME siRNAS ZUR REDUZIERUNG DER EXPRESSION VON ZIELGENEN
WO2003064625A2 (en) 2002-02-01 2003-08-07 Sequitur, Inc. Oligonucleotide compositions with enhanced efficiency
US20060009409A1 (en) 2002-02-01 2006-01-12 Woolf Tod M Double-stranded oligonucleotides
AU2003243541A1 (en) * 2002-06-12 2003-12-31 Ambion, Inc. Methods and compositions relating to labeled rna molecules that reduce gene expression
US20040248094A1 (en) * 2002-06-12 2004-12-09 Ford Lance P. Methods and compositions relating to labeled RNA molecules that reduce gene expression
EP1572956A2 (de) 2002-08-01 2005-09-14 City of Hope Verfahren und kits zur synthese von sirna-expressionskassetten
US7618948B2 (en) 2002-11-26 2009-11-17 Medtronic, Inc. Devices, systems and methods for improving and/or cognitive function through brain delivery of siRNA
US7829694B2 (en) * 2002-11-26 2010-11-09 Medtronic, Inc. Treatment of neurodegenerative disease through intracranial delivery of siRNA
US6852494B2 (en) * 2003-01-10 2005-02-08 Linden Technologies, Inc. Nucleic acid amplification
WO2004078941A2 (en) * 2003-03-06 2004-09-16 Oligo Engine, Inc. Modulation of gene expression using dna-rna hybrids
EP2361977A1 (de) 2003-04-15 2011-08-31 BASF Plant Science GmbH Nukleinsäuresequenzen, die für Proteine kodieren, die mit der abiotischen Stressantwort assoziiert sind, und transgene Pflanzenzellen, die mit denselben transformiert sind
EP1631268A2 (de) * 2003-05-21 2006-03-08 Board Of Regents The University Of Texas System Hemmung von protein kinase c-mu (pkd) als behandlung von herzhypertrophie und herzinsuffizienz
WO2005095622A2 (en) * 2004-03-26 2005-10-13 Van Andel Research Institute c-met siRNA ADENOVIRUS VECTORS INHIBIT CANCER CELL GROWTH, INVASION AND TUMORIGENICITY
CA2562673A1 (en) * 2004-04-22 2005-11-03 Yissum Research Development Company Of The Hebrew University Of Jerusal Em Universal target sequences for sirna gene silencing
NL1026335C2 (nl) * 2004-06-04 2005-12-06 Univ Delft Tech Werkwijze voor het maken van een dubbelstrengs polyribonucleotidenvolgorde met overhangend uiteinde, alsmede een werkwijze voor het vormen van een dubbelstrengs polynucleotidenconstruct en een toepassing.
CA2579927A1 (en) 2004-09-24 2006-03-30 Basf Plant Science Gmbh Plant cells and plants with increased tolerance to environmental stress
CN101495507B (zh) 2004-09-24 2013-07-17 巴斯福植物科学有限公司 编码与非生物性胁迫反应相关的蛋白质的核酸序列和具有增加的环境胁迫抗性的植物细胞和植物
US20060142228A1 (en) * 2004-12-23 2006-06-29 Ambion, Inc. Methods and compositions concerning siRNA's as mediators of RNA interference
DE202005004135U1 (de) * 2005-03-11 2005-05-19 Klocke Verpackungs-Service Gmbh Mehrkomponentenverpackung mit Applikator
EP1907546A2 (de) * 2005-05-31 2008-04-09 Devgen N.V. Rnai zur bekämpfung von insekten und arachniden
WO2006134162A2 (en) 2005-06-17 2006-12-21 Basf Plant Science Gmbh Lecitin-like protein kinase stress-related polypeptides and methods of use in plants
ES2437577T3 (es) 2005-07-18 2014-01-13 Basf Plant Science Gmbh Aumento del rendimiento en plantas que sobreexpresan los genes de ACCDP
EP1907555A2 (de) 2005-07-18 2008-04-09 BASF Plant Science GmbH Erhöhung des erntevolumens bei pflanzen durch überexpression der shsrp-gene
BRPI0614367A2 (pt) 2005-08-12 2009-08-18 Basf Plant Science Gmbh célula de planta, planta, semente, molécula de ácido nucleico isolado, construto de ácido nucleico, vetor, célula hospedeira, proteìna relacionada a estresse isolada, métodos para produzir uma planta transgênica, para modificar toleráncia a estresse de uma planta, para detectar estresse ambiental em células de planta ou plantas, para triar células de planta ou plantas para toleráncia e/ou resistência aumentada a estresse ambiental, e para reproduzir células de planta ou plantas para toleráncia e/ou resistência aumentada a estresse ambiental, e, uso de um ácido nucleico
US20070202515A1 (en) * 2005-10-12 2007-08-30 Pathologica, Llc. Promac signature application
WO2007092471A2 (en) * 2006-02-03 2007-08-16 The Regents Of The University Of California Methods for inhibition of lymphangiogenesis and tumor metastasis
MX2008012252A (es) 2006-03-24 2009-01-14 Basf Plant Science Gmbh Proteinas que se relacionan con la respuesta al estres abiotico y homologos.
EP4082551A1 (de) 2006-08-08 2022-11-02 Rheinische Friedrich-Wilhelms-Universität Bonn Struktur und verwendung von 5'-phosphat-oligonukleotiden
MX2009003824A (es) 2006-10-13 2010-04-07 Basf Plant Science Gmbh Plantas con rendimiento aumentado.
CN101631868B (zh) 2007-02-16 2016-02-10 巴斯福植物科学有限公司 用于在单子叶植物中调节胚特异性表达的核酸序列
AU2008252996B2 (en) 2007-05-22 2014-01-30 Basf Plant Science Gmbh Plants with increased tolerance and/or resistance to environmental stress and increased biomass production
EP2152890A1 (de) * 2007-05-23 2010-02-17 MannKind Corporation Multicistronische vektoren und verfahren zu deren konstruktion
MX2010002931A (es) 2007-09-18 2010-06-01 Basf Plant Science Gmbh Plantas con rendimiento incrementado.
CA2712326A1 (en) 2007-09-21 2009-03-26 Basf Plant Science Gmbh Plants with increased yield comprising increased glutamine synthetase activity
CA2708094A1 (en) 2007-12-19 2009-06-25 Basf Plant Science Gmbh Plants with increased yield and/or increased tolerance to environmental stress (iy-bm)
CN106841616B (zh) 2008-01-25 2019-06-04 茂体外尔公司 P53生物标记物
WO2009097508A2 (en) 2008-01-30 2009-08-06 Mcanulty, Jonathan Methods and compositions for wound healing
AU2009218478A1 (en) 2008-02-27 2009-09-03 Basf Plant Science Gmbh Plants with increased yield
EP2297323A1 (de) 2008-05-21 2011-03-23 Hartmann, Gunther 5 -triphosphat-oligonukleotid mit stumpfem ende und verwendugen davon
DE112009001994T5 (de) 2008-08-19 2012-01-19 Basf Plant Science Gmbh Pflanzen mit erhöhtem Ertrag durch Erhöhen oder Erzeugen einer oder mehrerer Aktivitäten in einer Pflanze oder einem Teil davon
WO2010034672A1 (en) 2008-09-23 2010-04-01 Basf Plant Science Gmbh Plants with increased yield (lt)
MX2011004269A (es) 2008-10-23 2011-05-30 Basf Plant Science Gmbh Un metodo para producir una celula transgenica con mayor contenido de acido gamma aminobutirico (gaba).
MX2011004270A (es) 2008-10-23 2011-07-13 Basf Plant Science Gmbh Plantas con rendimiento aumentado (nue).
EP2186822A1 (de) 2008-11-07 2010-05-19 Sanofi-Aventis Verwendung von Inhibitoren der Plac8-Aktivität zur Modulation von Adipogenese
EP2236607A1 (de) 2009-04-02 2010-10-06 Sanofi-Aventis Verwendung von Hemmern der St3Gla6-Aktivität zur Adipogenesemodulation
EP2253705A1 (de) 2009-05-20 2010-11-24 Sanofi-Aventis Verwendung von Hemmern der Zdhhc2-Aktivität zur Adipogenesemodulation
WO2011009801A1 (en) 2009-07-23 2011-01-27 Basf Plant Science Company Gmbh Plants with increased yield
US9409983B2 (en) 2009-07-23 2016-08-09 The Board Of Trustess Of The University Of Illinois Methods and compositions involving PBEF inhibitors for lung inflammation conditions and diseases
EP2308892A1 (de) 2009-10-01 2011-04-13 Sanofi-Aventis Verwendung von siRNA gegen Sipa1l1 zur Reduzierung von Lipogenese
CA2780707A1 (en) 2009-11-17 2011-05-26 Basf Plant Science Company Gmbh Plants with increased yield
WO2011094731A2 (en) 2010-02-01 2011-08-04 The Board Of Trustees Of The Leland Stanford Junior University Methods for diagnosis and treatment of non-insulin dependent diabetes mellitus
WO2013005211A2 (en) 2011-07-05 2013-01-10 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. Boron complexing plant materials and uses thereof cross-reference to related applications
WO2013036799A2 (en) 2011-09-09 2013-03-14 Fred Hutchinson Cancer Research Center Methods and compositions involving nkg2d inhibitors and cancer
WO2014045126A2 (en) 2012-09-18 2014-03-27 Uti Limited Partnership Treatment of pain by inhibition of usp5 de-ubiquitinase
EP2712870A1 (de) 2012-09-27 2014-04-02 Rheinische Friedrich-Wilhelms-Universität Bonn Neuartige RIG-I-Liganden und Herstellungsverfahren dafür
ES2904352T3 (es) 2012-11-06 2022-04-04 Imbed Biosciences Inc Procedimientos y composiciones para la curación de heridas
WO2014134179A1 (en) 2013-02-28 2014-09-04 The Board Of Regents Of The University Of Texas System Methods for classifying a cancer as susceptible to tmepai-directed therapies and treating such cancers
WO2015070009A2 (en) 2013-11-08 2015-05-14 The Board Of Regents Of The University Of Texas System Vh4 antibodies against gray matter neuron and astrocyte
US10265372B2 (en) 2014-08-12 2019-04-23 The Regents Of The University Of California Molecular composition for enhancing and rejuvenating maintenance and repair of mammalian tissues
US10278986B2 (en) 2014-08-14 2019-05-07 The Regents Of The University Of Colorado, A Body Corporate Antibody-siRNA conjugates and uses therefor
EA035799B1 (ru) 2015-05-18 2020-08-12 Зе Боард Оф Трастиз Оф Зе Леланд Стэнфорд Джуниор Юниверсити Способ лечения взрослого млекопитающего от когнитивного нарушения, ассоциированного со старением
EP3144014A1 (de) 2015-09-21 2017-03-22 Commissariat A L'energie Atomique Et Aux Energies Alternatives Synthetische tödliche arzneimittelkombination zur behandlung von nierenzellenkarzinom
KR20190059266A (ko) 2016-07-29 2019-05-30 임베드 바이오사이언시스 아이엔씨. 상처 치유를 위한 방법 및 조성물
US11286301B2 (en) 2017-02-28 2022-03-29 The Board Of Trustees Of The Leland Stanford Junior University Antifibrotic activity of CD47 blockade
EP3673066A4 (de) 2017-09-15 2021-05-26 Commonwealth Scientific and Industrial Research Organisation Rna-moleküle
EP3874273B1 (de) 2018-10-31 2024-03-27 Arizona Board of Regents on behalf of the University of Arizona Biomarker und verfahren zur verwendung bei strahlungsinduzierter lungenverletzung
WO2022006286A1 (en) 2020-06-30 2022-01-06 Lunglife Ai Methods for detecting lung cancer
EP4532772A1 (de) 2022-05-24 2025-04-09 Lunglife Ai, Inc. Verfahren zum nachweis zirkulierender genetisch abnormaler zellen

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4766072A (en) * 1985-07-17 1988-08-23 Promega Corporation Vectors for in vitro production of RNA copies of either strand of a cloned DNA sequence
JPH04507083A (ja) * 1989-05-19 1992-12-10 ヘム・リサーチ・インコーポレーテッド 規定された構造の短い治療用ｄｓＲＮＡ
CA2070632A1 (en) * 1990-01-10 1991-07-11 Bayer Corporation Use of dna-dependent rna polymerase transcripts as reporter molecules for signal amplification in nucleic acid hybridization assays

Also Published As

Publication number Publication date
JPH07505762A (ja) 1995-06-29
WO1993012229A1 (fr) 1993-06-24
DE69225074T2 (de) 1998-10-29
US5795715A (en) 1998-08-18
FR2685346B1 (fr) 1994-02-11
DE69225074D1 (de) 1998-05-14
EP0618966A1 (de) 1994-10-12
FR2685346A1 (fr) 1993-06-25
EP0618966B1 (de) 1998-04-08
JP3515108B2 (ja) 2004-04-05

Similar Documents

Publication Publication Date Title
ATE164883T1 (de) Verfahren zur vorbereitung von doppel strangiger rna und seine anwendungen
AU692403B2 (en) Analysis of gene expression by display of 3'-end restriction fragments of cdnas
EP0777747B1 (de) Nukleotid-sequenzierungsmethode
DE69307503D1 (de) Chemisches verfahren zur analyse von dns-sequenzen
DE68925717D1 (de) Verfahren und Reagenzkombination zur Bestimmung von Nukleotidsequenzen
EP1757695A3 (de) Prostata-spezifisches Membranantigen
ATE73502T1 (de) Verfahren und ausstattung zur bestimmung von spezifischen nukleotid-variationen und genetischen polymorphismen in nukleinsaeuren.
ATE204332T1 (de) Positionelle sequenzierung durch hybridisierung
EP0969102A3 (de) Primer, Sätze und Restriktions Fragmente und dessen Benutzung in selektive Restriktionsfragmentenamplifikation
EP0359789A1 (de) Verstärkung und nachweis von nukleinsäuresequenzen.
DE60220025D1 (de) Methoden und zusammensetzungen zur vervielfältigung von rna sequenzen
DE69428252D1 (de) Verfahren zur Verbesserung der Nukleinsäureamplifizierung
WO1993016094A3 (en) Applications of fluorescent n-nucleosides and fluorescent structural analogs of n-nucleosides
WO1998026093A3 (en) Fluorescent nucleotide analog hairpin formation for detection of nucleic acid hybridization
ATE542917T1 (de) Zusammensetzungen, verfahren und kits zur bestimmung des vorhandenseins von trichomonas vaginalis in einer testprobe
CA2349810C (en) Isometric primer extension method and kit for detection and quantification of specific nucleic acid
DE69815370D1 (de) Fluoreszend-konjugaten von nukleosiden und von nukleotiden, ihrer verfahren zur herstellung und ihrer verwendungen
WO2001088196A3 (en) Sequence based screening
EP1127159A1 (de) Verfahren zur indexierung und zur bestimmung der relativen konzentration von exprimierten mrnas
WO2002072881A3 (en) Method for the amplification and detection of hbv dna using a transcription based amplification
EP0286958A3 (de) Verfahren und Mittel zur Bestimmung von Nucleinsäuren
EP1536022A1 (de) Verfahren zum vergleich von genexpressionsniveaus
WO2005059505A3 (es) Método y kit para genotipificación de hla-b27 basados en la pcr en tiempo real
Palmirotta et al. Origin and gender determination of dried blood on a statue of the Virgin Mary
EP1679381A1 (de) Verfahren zur isomeren Primerverlängerung und Reagenziensatz zum Nachweis und zur Quantifizierung von spezifischen Nukleinsäuren